CareDx Inc (CDNA)-医療機器分野:企業M&A・提携分析

◆英語タイトル:CareDx Inc (CDNA) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011381
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:61
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CareDx Inc (CareDx) formerly XDx Inc, is a commercial stage molecular diagnostics company that develops, markets, and delivers diagnostic surveillance solutions for heart transplant patients. The company offers commercialized testing solution, the AlloMap heart transplant molecular test, is a noninvasive blood test used which helps clinicians to monitor and identify acute cellular rejection in heart transplant recipients. It develops products for transplant monitoring including AlloSure, a next-generation sequencing test to detect donor-derived cell-free DNA after transplantation. CareDx uses genomics and bioinformatics technology to develop its products. It offers novel surveillance management solutions to transform long-term patient care in transplantation. CareDx is headquartered in Brisbane, California, the US.

CareDx Inc (CDNA) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
CareDx Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
CareDx Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
CareDx Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
CareDx Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
CareDx Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
CareDx Inc, Medical Equipment, Deal Details 11
Venture Financing 11
CareDx Secures USD15 Million in Venture Funding 11
XDx Secures US$2.2 Million In Venture Financing 12
Private Equity 13
LinkMed Acquires 50% Stake In Olerup International From NorDiag 13
Partnerships 14
Diaxonhit Enters Into Licensing And Distribution Agreement With CareDx (XDx) For AlloMap Molecular Expression Testing 14
CML HealthCare And XDx Enter Into Licensing Agreement For AlloMap Heart Transplant Test 15
CareDx to Partner with Qiagen 16
CareDx Enters into Co-Development Agreement with Horizon Discovery 17
XDx Enters Into Agreement With LabCorp To Develop Lupus Flare Predictor Test 18
Olerup SSP Enters Into Distribution Agreement With Conexio Genomics 19
Olerup Enters Into Co-Marketing Agreement With QIAGEN 20
Equity Offering 21
CareDx Raises USD20 Million in Public Offering of Shares 21
CareDx Files Registration Statement to Raise Funds through Public Offering of Shares 23
CareDx Plans to Raise Funds through Private Placement of Shares upon Exercise of Warrants 24
CareDx Raises USD9 Million in Public Offering of Shares 25
CareDx Raises USD8 Million in Private Placement of Units 27
CareDx Plans to Raise up to USD23 Million in Public offering of Shares 29
CareDx Raise USD22 Million in Private Placement of Units 30
CareDx Raises USD14 Million in Private Placement of Units 31
CareDx Raises USD40 Million in IPO 33
Acquisition 35
Allenex To Sell 2.1% Stake In AnaMar To Koncentra For US$0.3 Million 35
SpinMed Completes Acquisition Of 73.4% Stake In OrtoWay From Allenex 36
CareDx Inc – Key Competitors 37
CareDx Inc – Key Employees 38
CareDx Inc – Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Recent Developments 40
Financial Announcements 40
Nov 09, 2017: CareDx Reports Third Quarter 2017 Financial Results 40
Aug 10, 2017: CareDx Reports Second Quarter 2017 Financial Results 41
Jul 13, 2017: CareDx provides 100,000th AlloMap to heart transplant patients 42
Jun 09, 2017: CareDx Reports First Quarter 2017 Financial Results 43
May 22, 2017: CareDx Reports Preliminary First Quarter 2017 Financial Results 44
Apr 21, 2017: CareDx Reports Fourth Quarter and Full Year 2016 Financial Results 45
Mar 15, 2017: CareDx Reports Preliminary Fourth Quarter and FY 2016 Financial Results 46
Nov 09, 2016: CareDx Reports Third Quarter 2016 Financial Results 48
Aug 10, 2016: CareDx Reports Preliminary Second Quarter 2016 Financial Results 49
May 06, 2016: CareDx Reports First Quarter 2016 Financial Results 51
Mar 24, 2016: CareDx Reports Fourth Quarter and Full Year 2015 Financial Results 52
Corporate Communications 53
Apr 21, 2017: CareDx Appoints Michael Bell as Chief Financial Officer 53
Jul 15, 2016: CareDx Appoints Douglas Miller to Its Board of Directors 54
Mar 29, 2016: CareDx Announces New Chief Commercial Officer Todd Whitson 55
Mar 24, 2016: CareDx Announces CFO Transition 56
Product News 57
May 30, 2017: CareDx Activities at European Federation of Immunogenetics Congress 57
Apr 28, 2016: CareDx to Present Clinical Abstracts Containing New Data at the 2016 ISHLT On AlloMap & AlloSure in heart transplant patients 58
03/08/2016: CareDx Receives Positive Coverage Decision for AlloMap From TRICARE Covering Over 9 Million Lives of U.S. Military Members and Their Families 59
01/12/2016: CareDx and Diaxonhit Announce Completion of Technology Transfer of AlloMap Test in Europe 60
Appendix 61
Methodology 61
About GlobalData 61
Contact Us 61
Disclaimer 61

List of Tables
CareDx Inc, Medical Equipment, Key Facts, 2016 2
CareDx Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
CareDx Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
CareDx Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
CareDx Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
CareDx Inc, Deals By Market, 2011 to YTD 2017 9
CareDx Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
CareDx Secures USD15 Million in Venture Funding 11
XDx Secures US$2.2 Million In Venture Financing 12
LinkMed Acquires 50% Stake In Olerup International From NorDiag 13
Diaxonhit Enters Into Licensing And Distribution Agreement With CareDx (XDx) For AlloMap Molecular Expression Testing 14
CML HealthCare And XDx Enter Into Licensing Agreement For AlloMap Heart Transplant Test 15
CareDx to Partner with Qiagen 16
CareDx Enters into Co-Development Agreement with Horizon Discovery 17
XDx Enters Into Agreement With LabCorp To Develop Lupus Flare Predictor Test 18
Olerup SSP Enters Into Distribution Agreement With Conexio Genomics 19
Olerup Enters Into Co-Marketing Agreement With QIAGEN 20
CareDx Raises USD20 Million in Public Offering of Shares 21
CareDx Files Registration Statement to Raise Funds through Public Offering of Shares 23
CareDx Plans to Raise Funds through Private Placement of Shares upon Exercise of Warrants 24
CareDx Raises USD9 Million in Public Offering of Shares 25
CareDx Raises USD8 Million in Private Placement of Units 27
CareDx Plans to Raise up to USD23 Million in Public offering of Shares 29
CareDx Raise USD22 Million in Private Placement of Units 30
CareDx Raises USD14 Million in Private Placement of Units 31
CareDx Raises USD40 Million in IPO 33
Allenex To Sell 2.1% Stake In AnaMar To Koncentra For US$0.3 Million 35
SpinMed Completes Acquisition Of 73.4% Stake In OrtoWay From Allenex 36
CareDx Inc, Key Competitors 37
CareDx Inc, Key Employees 38
CareDx Inc, Subsidiaries 39

★海外企業調査レポート[CareDx Inc (CDNA)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Schuler AG:企業の戦略・SWOT・財務情報
    Schuler AG - Strategy, SWOT and Corporate Finance Report Summary Schuler AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Obton AS:電力:M&Aディール及び事業提携情報
    Summary Obton A/S (Obton) is an investment company that offers management of assets within renewable energy. The company's investment process include screening process which inludes verification of prerequisites such as financial terms, amount of irradiation, power purchase agreement and feed-in tar …
  • Emgesa SA ESP:企業の戦略的SWOT分析
    Emgesa SA ESP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Alnylam Pharmaceuticals Inc (ALNY):医療機器:M&Aディール及び事業提携情報
    Summary Alnylam Pharmaceuticals Inc (Alnylam) is a biopharmaceutical company which discovers, develops and commercializes therapeutics based on Ribo Nucleic Acid interference (RNAi). The company offers a broad pipeline of investigational RNAi therapeutics in the areas of genetic medicines, hepatic i …
  • Fenchem Inc:企業の戦略・SWOT・財務分析
    Fenchem Inc - Strategy, SWOT and Corporate Finance Report Summary Fenchem Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • FLIR Systems Inc:企業のM&A・事業提携・投資動向
    FLIR Systems Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's FLIR Systems Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Lantheus Medical Imaging Inc-医療機器分野:企業M&A・提携分析
    Summary Lantheus Medical Imaging Inc (Lantheus Medical), a subsidiary of Lantheus Holdings, Inc., develops, manufactures, and commercializes diagnostic imaging agents and products for the diagnosis of conditions that affect heart, brain, lungs and other organs using echocardiography and nuclear imag …
  • Omnicom Group Inc. (OMC):企業の財務・戦略的SWOT分析
    Omnicom Group Inc. (OMC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Serco Inc:企業の戦略的SWOT分析
    Serco Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • New England Biolabs Inc-製薬・医療分野:企業M&A・提携分析
    Summary New England Biolabs Inc (NEB) is a life science company that develops recombinant and native enzymes for genomic research. The company offers products such as competent cells, DNA plasmids, protein tools, buffers and strains, and others. It has applications in cloning and synthetic biology, …
  • Denbury Resources Inc.:企業の戦略・SWOT・財務分析
    Denbury Resources Inc. - Strategy, SWOT and Corporate Finance Report Summary Denbury Resources Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Biolase, Inc. (BIOL)-医療機器分野:企業M&A・提携分析
    Summary Biolase, Inc. (Biolase) is medical device company which develops, manufactures, markets and sells dental lasers and related products. It also distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intra-oral scanners. The company offers two categories of laser s …
  • Aegean Airlines S.A.:企業の戦略・SWOT・財務情報
    Aegean Airlines S.A. - Strategy, SWOT and Corporate Finance Report Summary Aegean Airlines S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196):企業の財務・戦略的SWOT分析
    Summary Shanghai Fosun Pharmaceutical (Group) Co Ltd (Fosun Pharma), a subsidiary of Shanghai Fosun High Technology (Group) Co Ltd is a drug company that offers pharmaceutical products, medical diagnostic products and medical device products. The company’s pharmaceutical products include metabolism …
  • American Blue Ribbon Holdings LLC:企業の戦略・SWOT・財務分析
    American Blue Ribbon Holdings LLC - Strategy, SWOT and Corporate Finance Report Summary American Blue Ribbon Holdings LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Dairygold Co-operative Society Ltd:企業の戦略的SWOT分析
    Dairygold Co-operative Society Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Hyundai Heavy Industries Co., Ltd.:戦略・SWOT・企業財務分析
    Hyundai Heavy Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Hyundai Heavy Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Nexif Energy Management Pte Ltd:電力:M&Aディール及び事業提携情報
    Summary Nexif Energy Management Pte Ltd (Nexif Energy) a subsidiary of Nexif Pte Ltd invests in power projects in partnership with Denham Capital. The company carries out the development and management of power and infrastructure projects in South Asia and South East Asia. It develops and manages po …
  • AptarGroup Inc:企業の戦略・SWOT・財務分析
    AptarGroup Inc - Strategy, SWOT and Corporate Finance Report Summary AptarGroup Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Koln Dusseldorfer Deutsche Rheinschiffahrt Ag:企業の戦略・SWOT・財務分析
    Koln Dusseldorfer Deutsche Rheinschiffahrt Ag - Strategy, SWOT and Corporate Finance Report Summary Koln Dusseldorfer Deutsche Rheinschiffahrt Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆